Neonatal Respiratory Distress Syndrome Clinical Trial
Official title:
The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST): a Randomized Study Comparing Intravenous Ketamine With Sublingual 30% Glucose
The purpose of this study is to evaluate the efficacy and impact of intravenous ketamine or sublingual 30% glucose as sedation drugs used in preterm premature babies during the LISA procedure. The second goal is to compare the frequency of complications during LISA with both premedication regimens.
All infants fulfilling the inclusion criteria during the 12 months recruitment window will potentially be enrolled in this randomized controlled trial of LISA premedication. Written informed consent will be acquired from parents or legal guardians. After the consent, infants needing the LISA will receive premedication as follows: caffeine citrate according to the clinical routine at study site, and randomly, either ketamine or sublingual glucose 30%. This study is a pilot study and 60 patients that will be randomized 1:1. Ketamine will be given in slow intravenous injection over 60 seconds. Glucose 30% will be given sublingually in the volume of 1 mL. After two minutes (from the end of administration of the study drug or reference drug), laryngoscopy will be started. To assess the effectiveness of both types of sedation, patients will be assessed using two pain assessment scales - the COMFORT scale and the FANS scale. 10 minutes before the procedure, the first assessment in the COMFORT and FANS scales will take place. The next assessment on both scales will take place during the procedure. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02522455 -
Flow-cycled Ventilation in Preterm Infants
|
N/A | |
| Not yet recruiting |
NCT04019886 -
Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates
|
N/A | |
| Terminated |
NCT02999165 -
Breastfeeding Infants Receiving Respiratory Support Trial
|
||
| Completed |
NCT02112513 -
The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
|
||
| Completed |
NCT02824497 -
Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year
|
||
| Completed |
NCT04000568 -
Breathing Variability and NAVA in Neonates
|
||
| Completed |
NCT01926106 -
Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome
|
N/A | |
| Completed |
NCT02041676 -
Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation
|
N/A | |
| Completed |
NCT02819050 -
Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants
|
N/A | |
| Completed |
NCT02333669 -
Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome
|
N/A | |
| Completed |
NCT03446937 -
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
|
N/A | |
| Terminated |
NCT03235986 -
A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
|
Phase 2 | |
| Recruiting |
NCT06367881 -
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
|
Phase 1 |